Celularity, Inc. (CELU) vs Cassava Sciences, Inc. (FLNA)
Celularity, Inc. and Cassava Sciences, Inc. are both Biotechnology companies. Celularity, Inc. and Cassava Sciences, Inc. are of similar size ($38.2M and $37.8M). Cassava Sciences, Inc. grew revenue faster over the last twelve months: 277.6% against −51.0%. Cassava Sciences, Inc. has the higher net margin (0.00% vs −345.8%) and the higher return on invested capital (0.00% vs −1,070.9%). Across the 14 metrics below, Cassava Sciences, Inc. leads on 8 and Celularity, Inc. on 6.
Valuation
Profitability
| Metric | CELU | FLNA | Biotechnology median |
|---|---|---|---|
| Gross margin | 24.39% | 0.00% | 65.16% |
| Operating margin | (230.92%) | 0.00% | 0.00% |
| Net margin | (345.76%) | 0.00% | 0.00% |
| Free cash flow margin | (49.92%) | 0.00% | 0.00% |
| Return on equity | 628.23% | (55.78%) | (57.72%) |
| Return on assets | (76.50%) | (35.34%) | (49.22%) |
| Return on invested capital | (1,070.92%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack